Life Sciences Circle Event: Next Omics - Personalized Medicine Beyond Genomics
Wednesday, December 11 2013
5:45 pm – 8:45 pm
Location: The Broad Institute, 7 Cambridge Center, Cambridge, MA 02142
Over the past decade, the genomics revolution has led to the creation of numerous groundbreaking personalized therapies as well as multiple diagnostic and therapeutic targets. But what will the next field of biology be similar to that which created the genomics revolution? Join us to learn from thought leaders of several Cambridge-based “’omics” companies and institutions as they discuss their role in improving therapeutic effectiveness, realizing potential reductions in adverse effects, and the related promises of cost-effectiveness and efficiencies associated with these advances. We will gain insight from viewing the unique application of epigenetics, metabolomics, microbiomics, proteomics and more from these players to address our individual targeted medical needs and challenges. What are the challenges of commercializing new technologies and new areas of basic biological research? Will the next group of ‘omics contribute to the future of personalized therapies and ultimately improve healthcare outcomes and cost-effectiveness in our complex, expensive healthcare system?
- Katrine S. Bosley, Entrepreneur-in-Residence, The Broad Institute
- Clary Clish, PhD, Director of Metabolite Profiling, Broad Institute
- Bernat Olle, PhD, Principal, PureTech
- Robert Copeland, PhD, Executive Vice President and Chief Scientific Officer, Epizyme, Inc.
- Edward Driggers, PhD, Senior Director, Cell Metabolism, Agios Pharmaceuticals, Inc.